A Daily Network publication
Explore the network
ETF Daily
The Definitive Daily Read on Exchange-Traded Funds
Thursday, October 8, 2026The Morning Brief →Sign in

Who holds CRSPCRISPR THERAPEUTICS AG

13 funds on our shelf carry CRISPR THERAPEUTICS AG — heaviest hand: GNOM at 2.71% of its book.

FundWeightFund assetsShares held
GNOMGlobal X Genomics & Biotechnology ETFINDEX2.71%$85M50,453
IDNAiShares Genomics Immunology and Healthcare ETFINDEX1.40%$317M79,638
XBIState Street SPDR S&P Biotech ETFINDEX1.02%$10.3B2,006,430
IBBiShares Biotechnology ETFINDEX0.37%$10.6B679,191
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.37%$112M7,160
VTWVVanguard Russell 2000 Value ETFINDEX0.30%$813M75,907
IWNiShares Russell 2000 Value ETFINDEX0.28%$13.9B759,792
IWMiShares Russell 2000 ETFINDEX0.17%$79.3B2,339,755
VTWOVanguard Russell 2000 ETFINDEX0.17%$9.9B535,930
RSSLGlobal X Russell 2000 ETFINDEX0.16%$1.5B42,698
ISCViShares Morningstar Small-Cap Value ETFINDEX0.16%$661M20,690
PDNInvesco RAFI Developed Markets ex-U.S. Small-Mid ETFINDEX0.11%$349M6,887
XTiShares Exponential Technologies ETFINDEX0.03%$4.1B18,651

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

Every weekday · 6:30 a.m. ET

The Morning Brief

ETF launches, fund research, and market coverage in your inbox every weekday. Free.